Thrombomodulin expression impacts the recurrence and long‐term survival in pancreatic cancer-Reference-Cited by-同舟云学术

Thrombomodulin expression impacts the recurrence and long‐term survival in pancreatic cancer

Published:2021-02-20 Issue:4 Volume:5 Page:567-574
ISSN:2475-0328
Container-title:Annals of Gastroenterological Surgery
language:en
Short-container-title:Ann Gastroenterol Surg

Author:

Sugano Hiroshi¹²,Shirai Yoshihiro¹²^ORCID,Sato Shun³,Hamatani Shigeharu³,Hamura Ryoga¹²^ORCID,Taniai Tomohiko¹²,Horiuchi Takashi¹²,Gocho Takeshi¹,Eto Ken¹,Ikegami Toru¹^ORCID

Affiliation:

1. Department of Surgery The Jikei University School of Medicine Tokyo Japan

2. Division of Gene Therapy Research Center for Medical Science The Jikei University School of Medicine Tokyo Japan

3. Department of Pathology The Jikei University School of Medicine Tokyo Japan

Publisher

Wiley

Subject

Gastroenterology,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ags3.12447

Reference31 articles.

1. Cancer statistics, 2019

2. Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer

3. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

4. FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

5. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haemostatic Gene Expression in Cancer-Related Immunothrombosis: Contribution for Venous Thromboembolism and Ovarian Tumour Behaviour;Cancers;2024-06-27

2. Group XIV C-type lectins: emerging targets in tumor angiogenesis;Angiogenesis;2024-03-12

3. The role of thrombomodulin in modulating ITGB3 expression and its implications for triple‐negative breast cancer progression;Cell Biology International;2023-12-11

4. Role of Fibrinolytic Mechanisms in Breast Cancer Diagnosis, Prognosis, and Treatment;Breast Cancer: From Bench to Personalized Medicine;2022